In focus · trending topic

Commercial Launch

3 stories · following the connections

Adamas Announces U.S. Commercial Launch of GOCOVRI™ the First and Only FDA-approved Medication for the Treatment of Dyskinesia in Parkinson’s Disease Patients

By Nasdaq OMXJan 8, 2018, 9:41 PM UTC

Great Basin Scientific Announces Commercial Launch of Bordetella Direct Test

By Nasdaq OMXMay 16, 2017, 11:01 AM UTC

Great Basin Scientific Announces Commercial Launch of Bordetella Direct Test

By Nasdaq OMXMay 16, 2017, 11:01 AM UTC